name: Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration; each additional 25 sq cm of harvested skin or part thereof (List separately in addition to code for primary procedure)


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs; first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to trunk, arms, legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms, legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, arms, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs; each additional 480 sq cm or part thereof (List separately in addition to code for primary procedure)


name: Application of skin cell suspension self skin graft to wound and donor sites to trunk, arms, legs, each additional 480 sq cm


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms,


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms, legs, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to legs, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, arms, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, legs, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to face, scalp, eyelids, mouth, neck, ears, eye sockets, genitalia, hands, feet, and/or multiple fingers/toes, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to face, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to face, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites. including application of primary dressing, to mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 480 sq cm or part thereof (List separately in addition to code for primary procedure)


name: Application of skin cell suspension self skin graft to wound and donor sites to face, scalp, eyelids, mouth, neck, ears, eye sockets, genitalia, hands, feet, and/or multiple fingers/toes, each additional 480 sq cm


name: Application of skin cell suspension self skin graft to wound and donor sites, each additional 480 sq cm or part thereof to hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia ,each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Arthroplasty, intercarpal or carpometacarpal joints


name: Replacement of joint between wrist and fingers using tissue


name: Arthroplasty, intercarpal or carpometacarpal joints; suspension, including transfer or transplant of tendon, with interposition, when performed


name: Replacement of joint between wrist and fingers using tendon or stitches


name: Suspension arthroplasty of carpometacarpal joint including transfer or transplant of tendon


name: Suspension arthroplasty of intercarpal joint including transfer or transplant of tendon


name: Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for development of genetically modified autologous CAR-T cells, per day


name: Chimeric antigen receptor T-cell (CAR-T) therapy, preparation of blood-derived T lymphocytes for cryopreservation


name: Chimeric antigen receptor T-cell (CAR-T) therapy, preparation of blood-derived T lymphocytes for storage


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s)


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 5 cm or less


name: Removal or destruction of growth(s) in the abdomen, 5.0 cm or less


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 5.1 to 10 cm


name: Removal or destruction of growth(s) in the abdomen, 5.1 to 10.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 10.1 to 20 cm


name: Removal or destruction of growth(s) in the abdomen, 10.1 to 20.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 20.1 to 30 cm


name: Removal or destruction of growth(s) in the abdomen, 20.1 to 30.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); greater than 30 cm


name: Removal or destruction of growth(s) in the abdomen, more than 30.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation, including suprapubic tube placement during the same session and placement of an endorectal cooling device, when performed


name: Insertion of transducer through urethra for delivery of heat ultrasound for destruction of prostate tissue


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation with suprapubic tube placement


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation with suprapubic tube placement and placement of an endorectal cooling device


name: Cystourethroscopy with insertion of temporary device for ischemic remodeling (ie, pressure necrosis) of bladder neck and prostate


name: Insertion of a temporary device for pressure necrosis of bladder neck and prostate using an endoscope


name: Cystourethroscopy with insertion of temporary device for ischemic remodeling of bladder neck


name: Cystourethroscopy with insertion of temporary device for ischemic remodeling of bladder neck and prostate


name: Cystourethroscopy with insertion of temporary device for ischemic remodeling of prostate


name: Cystourethroscopy with insertion of temporary device for pressure necrosis of bladder neck


name: Cystourethroscopy with insertion of temporary device for pressure necrosis of bladder neck and prostate


name: Cystourethroscopy with insertion of temporary device for pressure necrosis of prostate


name: Catheterization with removal of temporary device for ischemic remodeling (ie, pressure necrosis) of bladder neck and prostate


name: Removal of temporary device for pressure necrosis of bladder neck and prostate using catheterization


name: Catheterization with removal of temporary device for ischemic remodeling of bladder neck


name: Catheterization with removal of temporary device for ischemic remodeling of bladder neck and prostate


name: Catheterization with removal of temporary device for ischemic remodeling of prostate


name: Catheterization with removal of temporary device for pressure necrosis of bladder neck


name: Catheterization with removal of temporary device for pressure necrosis of bladder neck and prostate


name: Catheterization with removal of temporary device for pressure necrosis of prostate


name: Ablation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablation


name: Destruction of prostate tissue through urethra using heat ultrasound with MRI guidance


name: Transurethral ablation of prostate tissue using thermal ultrasound


name: Transurethral ablation of prostate tissue using thermal ultrasound, with magnetic resonance imaging guidance


name: Ablation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablation; with insertion of transurethral ultrasound transducer for delivery of thermal ultrasound, including suprapubic tube placement and placement of an endorectal cooling device, when performed


name: Insertion of ultrasound transducer through urethra for delivery of heat ultrasound for destruction of prostate tissue using MRI guidance


name: Transurethral ablation of prostate tissue using thermal ultrasound, with insertion of transurethral ultrasound delivery of thermal ultrasound


name: Transurethral ablation of prostate tissue using thermal ultrasound, with insertion of transurethral ultrasound delivery of thermal ultrasound, with suprapubic tube placement and placement of an endorectal cooling device


name: Transurethral ablation of prostate tissue using thermal ultrasound, with magnetic resonance imaging guidance, with insertion of transurethral ultrasound delivery of thermal ultrasound


name: Transurethral ablation of prostate tissue using thermal ultrasound, with magnetic resonance imaging guidance, with insertion of transurethral ultrasound delivery of thermal ultrasound, with suprapubic tube placement and placement of an endorectal cooling device


name: Ablation of 1 or more thyroid nodule(s), one lobe or the isthmus, percutaneous, including imaging guidance, radiofrequency


name: Destruction using heat of one or more nodules on one thyroid lobe


name: Percutaneous radiofrequency ablation of thyroid nodule from one thyroid lobe


name: Percutaneous radiofrequency ablation of thyroid nodule from one thyroid lobe, with imaging guidance


name: Percutaneous radiofrequency ablation of thyroid nodule from thyroid isthmus


name: Percutaneous radiofrequency ablation of thyroid nodule from thyroid isthmus, with imaging guidance


name: Ablation of 1 or more thyroid nodule(s), additional lobe, percutaneous, including imaging guidance, radiofrequency (List separately in addition to code for primary procedure)


name: Destruction using heat of one or more nodules on additional thyroid lobe


name: Percutaneous radiofrequency ablation of thyroid nodule, additional lobe


name: Percutaneous radiofrequency ablation of thyroid nodule, additional lobe, with imaging guidance


name: Magnetic resonance image guided high intensity focused ultrasound (MRgFUS), stereotactic ablation of target, intracranial, including stereotactic navigation and frame placement, when performed


name: MRI guided high intensity focused ultrasound, computer-assisted destruction of intracranial tissue


name: Intracranial stereotactic ablation of target using magnetic resonance image guided high intensity focused ultrasound (MRgFUS)


name: Intracranial stereotactic ablation of target using magnetic resonance image guided high intensity focused ultrasound (MRgFUS), with stereotactic navigation and frame placement


name: thoracic fascial plane block, unilateral


name: Thoracic fascial plane block, unilateral; by injection(s), including imaging guidance, when performed


name: Unilateral thoracic fascial plane block by injection


name: Unilateral thoracic fascial plane block by injection, with imaging guidance


name: Thoracic fascial plane block, unilateral; by continuous infusion(s), including imaging guidance, when performed


name: Unilateral thoracic fascial plane block by continuous infusion


name: Unilateral thoracic fascial plane block by continuous infusion, with imaging guidance


name: Thoracic fascial plane block, bilateral; by injection(s), including imaging guidance, when performed


name: Bilateral thoracic fascial plane block by injection


name: Bilateral thoracic fascial plane block by injection, with imaging guidance


name: Thoracic fascial plane block, bilateral; by continuous infusion(s), including imaging guidance, when performed


name: Bilateral thoracic fascial plane block by infusion(s)


name: Bilateral thoracic fascial plane block by continuous infusion


name: Bilateral thoracic fascial plane block by continuous infusion, with imaging guidance


name: lower extremity fascial plane block, unilateral


name: Lower extremity fascial plane block, unilateral; by injection(s), including imaging guidance, when performed


name: Unilateral lower extremity fascial plane block by injection


name: Unilateral lower extremity fascial plane block by injection, with imaging guidance


name: Lower extremity fascial plane block, unilateral; by continuous infusion(s), including imaging guidance, when performed


name: Unilateral lower extremity fascial plane block by infusion(s)


name: Unilateral lower extremity fascial plane block by continuous infusion


name: Unilateral lower extremity fascial plane block by continuous infusion, with imaging guidance


name: Implantation of iris prosthesis, including suture fixation and repair or removal of iris, when performed


name: Implantation of iris prosthesis with suture fixation


name: Implantation of iris prosthesis with suture fixation and removal of iris


name: Implantation of iris prosthesis with suture fixation and repair of iris


name: Magnetic Resonance Safety Implant/Foreign Body Procedures


name: MR safety implant and/or foreign body assessment by trained clinical staff, including identification and verification of implant components from appropriate sources (eg, surgical reports, imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report


name: MR safety implant and/or foreign body assessment by trained clinical staff, including identification and verification of implant components from appropriate sources (eg, surgical reports, imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report; initial 15 minutes


name: Assessment by trained clinical staff of implant and/or foreign body for MR safety, including identification and verification of implant components from appropriate sources, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report, initial 15 minutes


name: MR foreign body assessment by trained clinical staff, with identification and verification of implant components from medical device databases, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from device vendors, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from imaging reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from review of prior imaging, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from surgical reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from device vendors, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from imaging reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from medical device databases, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from review of prior imaging, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from surgical reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from device vendors, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from imaging reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from medical device databases, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from review of prior imaging, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from surgical reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, initial 15 minutes


name: MR safety implant and/or foreign body assessment by trained clinical staff, including identification and verification of implant components from appropriate sources (eg, surgical reports, imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report; each additional 30 minutes (List separately in addition to code for primary procedure)


name: Assessment by trained clinical staff of implant and/or foreign body for MR safety, including identification and verification of implant components from appropriate sources, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance with written report, each additional 30 minutes


name: MR foreign body assessment by trained clinical staff, with identification and verification of implant components from medical device databases, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from device vendors, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from imaging reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from review of prior imaging, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety foreign body assessment by trained clinical staff, with identification and verification of implant components from surgical reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from device vendors, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from imaging reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from medical device databases, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from review of prior imaging, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant and foreign body assessment by trained clinical staff, with identification and verification of implant components from surgical reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from device vendors, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from imaging reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from medical device databases, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from review of prior imaging, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety implant assessment by trained clinical staff, with identification and verification of implant components from surgical reports, analyzing current MR conditional status of individual components and systems, and consulting published professional guidance, with written report, each additional 30 minutes


name: MR safety determination by a physician or other qualified health care professional responsible for the safety of the MR procedure, including review of implant MR conditions for indicated MR examination, analysis of risk vs clinical benefit of performing MR examination, and determination of MR equipment, accessory equipment, and expertise required to perform examination, with written report


name: MR safety determination by a physician responsible for the safety of the MR procedure, with review of implant MR conditions for indicated MR examination, analysis of risk vs clinical benefit of performing MR examination, and determination of MR equipment, accessory equipment, and expertise required to perform examination, with written report


name: MR safety determination by a qualified health care professional responsible for the safety of the MR procedure, with review of implant MR conditions for indicated MR examination, analysis of risk vs clinical benefit of performing MR examination, and determination of MR equipment, accessory equipment, and expertise required to perform examination, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist or MR safety expert, with review and analysis by physician or other qualified health care professional to prioritize and select views and imaging sequences, to tailor MR acquisition specific to restrictive requirements or artifacts associated with MR conditional implants or to mitigate risk of non-conditional implants or foreign bodies, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by a MR safety expert, with review and analysis by a physician to mitigate risk of non-conditional implants or foreign bodies, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by a MR safety expert, with review and analysis by a physician to tailor MR acquisition specific to restrictive requirements or artifacts associated with MR conditional implants, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by a MR safety expert, with review and analysis by a qualified healthcare professional to mitigate risk of non-conditional implants or foreign bodies, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by a MR safety expert, with review and analysis by a qualified healthcare professional to prioritize and select views and imaging sequences, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by a MR safety expert, with review and analysis by a qualified healthcare professional to tailor MR acquisition specific to restrictive requirements or artifacts associated with MR conditional implants, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by a MR safety expert, with review and analysis by physician to prioritize and select views and imaging sequences, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist, with review and analysis by a physician to mitigate risk of non-conditional implants or foreign bodies, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist, with review and analysis by a physician to tailor MR acquisition specific to restrictive requirements or artifacts associated with MR conditional implants, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist, with review and analysis by a qualified healthcare professional to mitigate risk of non-conditional implants or foreign bodies, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist, with review and analysis by a qualified healthcare professional to prioritize and select views and imaging sequences, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist, with review and analysis by a qualified healthcare professional to tailor MR acquisition specific to restrictive requirements or artifacts associated with MR conditional implants, with written report


name: MR safety medical physics examination customization, planning and performance monitoring by medical physicist, with review and analysis by physician to prioritize and select views and imaging sequences, with written report


name: MR safety implant electronics preparation under supervision of physician or other qualified health care professional, including MR-specific programming of pulse generator and/or transmitter to verify device integrity, protection of device internal circuitry from MR electromagnetic fields, and protection of patient from risks of unintended stimulation or heating while in the MR room, with written report


name: Preparation under supervision of physician or other qualified health care professional of electronics for MR safety, including MR-specific programming of pulse generator and/or transmitter to verify device integrity, protection of device internal circuitry from MR electromagnetic fields, and protection of patient from risks of unintended stimulation or heating while in the MR room, with written report


name: MR safety implant electronics preparation under supervision of physician, including MR-specific programming of pulse generator and/or transmitter to verify device integrity, protection of device internal circuitry from MR electromagnetic fields, and protection of patient from risks of unintended stimulation or heating while in the MR room, with written report


name: MR safety implant electronics preparation under supervision qualified health care professional, including MR-specific programming of pulse generator and/or transmitter to verify device integrity, protection of device internal circuitry from MR electromagnetic fields, and protection of patient from risks of unintended stimulation or heating while in the MR room, with written report


name: MR safety implant positioning and/or immobilization under supervision of physician or other qualified health care professional, including application of physical protections to secure implanted medical device from MR-induced translational or vibrational forces, magnetically induced functional changes, and/or prevention of radiofrequency burns from inadvertent tissue contact while in the MR room, with written report


name: MR safety implant positioning and/or immobilization under supervision of physician, with application of physical protections to secure implanted medical device from MR-induced translational or vibrational forces, magnetically induced functional changes, and/or prevention of radiofrequency burns from inadvertent tissue contact while in the MR room, with written report


name: MR safety implant positioning and/or immobilization under supervision of qualified healthcare professional, with application of physical protections to secure implanted medical device from MR-induced translational or vibrational forces, magnetically induced functional changes, and/or prevention of radiofrequency burns from inadvertent tissue contact while in the MR room, with written report


name: Delivery of radiation therapy per dose to 1 or more lesions not to exceed 5 doses


name: Cytogenomic (genome-wide) analysis, hematologic malignancy, structural variants and copy number variants, optical genome mapping (OGM)


name: Optical genome mapping for hematologic malignancy


name: Test for detecting genes associated with inherited breast cancer-related disorders, genomic sequence analysis, at least 5 genes


name: Test for detecting genes associated with inherited colon cancer-related disorders, genomic sequence analysis, at least 5 genes


name: Test for detecting genes associated with inherited neuroendocrine tumor-related disorders, genomic sequence analysis, at least 5 genes


name: Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), utilizing vaginal-fluid specimens, algorithm reported as positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei, when reported


name: Test for detection of bacteria causing vaginosis and vaginitis


name: Detection of bacterial vaginosis and vaginitis by real-time PCR amplification of DNA markers for Atopobium vaginae, Atopobium species, and Megasphera type 1, Bacterial Vaginosis-Associated Bacteria 2 (BVAB-2), in vaginal fluid specimen, algorithm reported as positive or negative for high likelihood of bacterial vaginosis, with separate detection of Trichomonas vaginalis and Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata/Candida krusei


name: Transplantation medicine (allograft rejection, kidney), mRNA, gene expression profiling by quantitative polymerase chain reaction (qPCR) of 139 genes, utilizing whole blood, algorithm reported as a binary categorization as transplant excellence, which indicates immune quiescence, or not transplant excellence, indicating subclinical rejection


name: Test for detecting 139 genes associated with kidney transplant rejection


name: Kidney allograft rejection mRNA gene expression profiling by quantitative polymerase chain reaction (qPCR) of 139 genes, in whole blood, algorithm reported as a binary categorization as transplant excellence, which indicates immune quiescence, or not transplant excellence, indicating subclinical rejection


name: Tau, phosphorylated (eg, pTau 181, pTau 217), each


name: Streptococcus pneumoniae antibody (IgG), serotypes, multiplex immunoassay, quantitative


name: Test for streptococcus pneumonia antibody


name: Infectious agent detection by nucleic acid (DNA or RNA); Helicobacter pylori (H. pylori), clarithromycin resistance, amplified probe technique


name: Detection test by nucleic acid for helicobacter pylori clarithromycin resistance, amplified probe technique


name: Detection of helicobacter pylori (H. pylori) for clarithromycin resistance by amplified DNA probe technique


name: Detection of helicobacter pylori (H. pylori) for clarithromycin resistance by amplified RNA probe technique


name: Human Papillomavirus (HPV) detection by DNA for high-risk types, pooled result


name: Human Papillomavirus (HPV) detection by RNA for high-risk types, pooled result


name: Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), separately reported high-risk types (eg, 16, 18, 31, 45, 51, 52) and high-risk pooled result(s)


name: Detection test by nucleic acid for Human Papillomavirus (HPV), separately reported high-risk types


name: Human Papillomavirus (HPV) detection by DNA for high-risk types, high-risk pooled result(s)


name: Human Papillomavirus (HPV) detection by DNA for high-risk types, separately reported high-risk types


name: Human Papillomavirus (HPV) detection by DNA for high-risk types, separately reported high-risk types and high-risk pooled result(s)


name: Human Papillomavirus (HPV) detection by RNA for high-risk types, high-risk pooled result(s)


name: Human Papillomavirus (HPV) detection by RNA for high-risk types, separately reported high-risk types


name: Human Papillomavirus (HPV) detection by RNA for high-risk types, separately reported high-risk types and high-risk pooled result(s)


name: Infectious agent detection by nucleic acid (DNA or RNA); Mycobacterium tuberculosis, rifampin resistance, amplified probe technique


name: Detection test by nucleic acid for mycobacterium tuberculosis rifampin resistance


name: Detection of Mycobacterium tuberculosis for rifampin resistance by amplified DNA probe technique


name: Detection of Mycobacterium tuberculosis for rifampin resistance by amplified RNA probe technique


name: Infectious agent detection by nucleic acid (DNA or RNA); Pneumocystis jirovecii, amplified probe technique


name: Detection test by nucleic acid for pneumocystis jirovecii


name: Detection of Pneumocystis jirovecii by amplified DNA probe technique


name: Detection of Pneumocystis jirovecii by amplified RNA probe technique


name: Spheroid cell culture in 3D microenvironment with 12 drug panel, with brain metastasis-response prediction for each drug


name: Spheroid cell culture in 3D microenvironment with 12 drug panel, with brain-response prediction for each drug


name: Oncology (oropharyngeal or anal), evaluation of 17 DNA biomarkers using droplet digital PCR (ddPCR), cell-free DNA, algorithm reported as a prognostic risk score for cancer recurrence


name: Evaluation of 17 DNA biomarkers reported as a risk score for tonsil or anal cancer recurrence


name: Evaluation of 18 genes by mRNA gene expression profiling in first-catch urine, algorithm reported as percentage of likelihood of detecting clinically significant prostate cancer


name: mRNA expression profiling of 6 single-nucleotide polymorphisms (SNPs) in urine reported as s risk score for urothelial carcinoma


name: Screening test for 8 RNA markers and blood in stool reported as positive or negative for colorectal cancer risk


name: Analysis of DNA biomarker response to anti-cancer therapy reported as a change from baseline


name: Analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations


name: Genomic analysis panel of 26 genes from cheek swab, report including metabolizer status and risk of drug toxicity by psychiatric condition


name: Genomic analysis panel, including variant analysis of 26 genes, in buccal swab, report including metabolizer status and risk of drug toxicity by condition


name: Exosome-based analysis of 53 small non coding RNAs (sncRNAs) in urine, reported as risk for prostate cancer


name: Genome rapid sequence analysis, each comparator gene (eg, parents, siblings) for unexplained constitutional or heritable disorder or syndrome


name: Ultra-rapid genome sequence analysis for unexplained constitutional or heritable disorder or syndrome


name: Testing for Human papillomavirus (HPV) from throat swab


name: Glycine receptor alpha1 IgG live cell-binding assay in serum or cerebral spinal fluid (CSF)


name: Qualitative live cell-binding assay (LCBA) for glycine receptor alpha1 IgG in cerebrospinal fluid (CSF)


name: Qualitative live cell-binding assay (LCBA) for glycine receptor alpha1 IgG in serum


name: Kelch-like protein 11 (KLHL11) antibody cell-binding assay in serum or cerebrospinal fluid (CSF)


name: Qualitative cell-binding assay for kelch-like protein 11 (KLHL11) antibody in cerebrospinal fluid (CSF)


name: Qualitative cell-binding assay for kelch-like protein 11 (KLHL11) antibody in serum


name: Testing for 5 DNA regulatory markers by quantitative PCR in whole blood, reported as likelihood of prostate cancer


name: Genomic analysis panel of 25 genes to evaluation drug metabolism


name: Chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), reported based on cytotoxicity percentage observed for a minimum of 14 drugs or drug combinations


name: Plasma analysis of 388 proteins reported as clinical benefit from immune checkpoint inhibitor therapy in lung cancer


name: Variant analysis of gene-drug interactions of 33 genes from cheek swab to evaluate for adverse drug reactions and drug response


name: Cardiology (coronary heart disease [CHD]), DNA, analysis of 5 single-nucleotide polymorphisms (SNPs) (rs11716050 [LOC105376934], rs6560711 [WDR37], rs3735222 [SCIN/LOC107986769], rs6820447 [intergenic], and rs9638144 [ESYT2]) and 3 DNA methylation markers (cg00300879 [transcription start site {TSS200} of CNKSR1], cg09552548 [intergenic], and cg14789911 [body of SPATC1L]), qPCR and digital PCR, whole blood, algorithm reported as a 4-tiered risk score for a 3-year risk of symptomatic CHD


name: qPCR and digital PCR DNA analysis of 5 single-nucleotide polymorphisms (SNPs) and 3 DNA methylation markers in whole blood, reported as a 4-tiered risk score for a 3-year risk of symptomatic coronary heart disease (CHD)


name: Cardiology (coronary heart disease [CHD]), DNA, analysis of 10 single-nucleotide polymorphisms (SNPs) (rs710987 [LINC010019], rs1333048 [CDKN2B-AS1], rs12129789 [KCND3], rs942317 [KTN1-AS1], rs1441433 [PPP3CA], rs2869675 [PREX1], rs4639796 [ZBTB41], rs4376434 [LINC00972], rs12714414 [TMEM18], and rs7585056 [TMEM18]) and 6 DNA methylation markers (cg03725309 [SARS1], cg12586707 [CXCL1], cg04988978 [MPO], cg17901584 [DHCR24-DT], cg21161138 [AHRR], and cg12655112 [EHD4]), qPCR and digital PCR, whole blood, algorithm reported as detected or not detected for CHD


name: qPCR and digital PCR DNA, analysis of 10 single-nucleotide polymorphisms (SNPs) and 6 DNA methylation markers in whole blood, reported as detected or not detected for evaluation of coronary heart disease (CHD)


name: Infectious disease (bacterial, fungal, or viral infection), semiquantitative biomechanical assessment (via deformability cytometry), whole blood, with algorithmic analysis and result reported as an index


name: Semiquantitative biomechanical assessment (via deformability cytometry), in whole blood, with algorithmic analysis and result reported as an index for bacterial infection


name: Semiquantitative biomechanical assessment (via deformability cytometry), in whole blood, with algorithmic analysis and result reported as an index for fungal infection